Room to Run, the Race for a COVID-19 Antibody Drug, and the Most Underappreciated Risk
Podcast |
The Exchange
Publisher |
CNBC
Media Type |
audio
Categories Via RSS |
Business
Investing
News
Publication Date |
May 27, 2020
Episode Duration |
00:46:54

Another rally on Wall Street and two strategists both say there’s more room to run…where they’re finding opportunities.

The CEO of AbCellera joins to discuss the company’s partnership with Eli Lilly in the race for a COVID-19 antibody drug.

And two policy strategists weigh in one of the biggest and most underappreciated risks for the market right now.

Plus, a ‘cool’ trade for the summer.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review